Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro
Chemotherapy plays a major role in the treatment of cancer, but it still has great limitations in anti-tumor effect. Carboplatin (CAR) is the first-line drug in the treatment of non-small cell lung cancer, but the therapeutic effect is demonstrated weak. Therefore, we modified CAR with hexadecyl cha...
Saved in:
Main Authors: | Tingting Lang (Author), Nuannuan Li (Author), Jing Zhang (Author), Yi Li (Author), Rong Rong (Author), Yuanlei Fu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy
by: Yuanlei Fu, et al.
Published: (2023) -
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
by: Nuannuan Li, et al.
Published: (2021) -
Redox-Responsive Lipidic Prodrug Nano-Delivery System Improves Antitumor Effect of Curcumin Derivative C210
by: Xin Guo, et al.
Published: (2023) -
Nano-scale drug delivery systems for carboplatin: A comprehensive review
by: Mehrab Pourmadadi, et al.
Published: (2023) -
Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
by: Lu Yang, et al.
Published: (2021)